Strategic Growth Drivers Shaping the DNA And Gene Chip Market Outlook 2025- 2034:Early Cancer Detection Driving Growth Of DNA And Gene Chip Market
Discover trends, market shifts, and competitive outlooks for the dna and gene chip industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the DNA And Gene Chip Market From 2025 To 2029?
In the past few years, the DNA and gene chip market has seen a swift surge in its size. It is predicted to rise from $8.19 billion in 2024 to $9.27 billion in 2025, representing an impressive compound annual growth rate (CAGR) of 13.1%. The remarkable growth over the historic period is due to factors such as significant advancements in genomic research, the increasing prominence of personalized medicine, accomplishments in the human genome project, progress in drug discovery and development, and the identification of disease biomarkers.
The market size for DNA and gene chips is anticipated to experience swift expansion in the upcoming years, with a prediction to reach $15.35 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 13.4%. Key factors propelling growth during the prediction period include progress in precision medicine, biomarker discovery expansion, the rise of personalized therapeutics, and their application in cancer research alongside increased research funding. On the horizon, key trends feature technological advancements, product innovations, regulatory structure and adherence, emphasis on rare diseases, and ongoing reduction in costs.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp
Which Factors and External Forces Are Driving Demand in the DNA And Gene Chip Market?
The escalating need for early identification of cancer is greatly influencing the expansion of the DNA and gene market. Cancer is an extensive category of diseases that can occur in virtually any organ or tissue when abnormal cells proliferate uncontrollably, breach normal cell barriers to assault adjacent organs, and disseminate to other areas of the body. DNA and gene chips are employed to assess gene expression patterns, decipher the genetic and epigenetic landscape, and gauge genomic regulatory elements bound by cancer transcription factors in malignant cells. For example, the American Cancer Society, a community-based, voluntary health organization in the US, estimated in 2022, that around 1.9 million fresh cases of cancer would be diagnosed and 609,360 deaths from cancer would transpire in the United States. Hence, escalating need for early identification of cancer is propelling the development of the DNA and gene chip market.
Which Segments in the DNA And Gene Chip Offer the Most Growth?
The DNA and gene chip market covered in this report is segmented –
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users
Subsegments:
1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays
2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays
3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp
What Are the Fastest-Growing Geographies in the DNA And Gene Chip Market?
North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theDNA And Gene Chip Market’s Growth?
One of the leading trends in the DNA and gene chip market is the increase in strategic alliances and collaborations. Numerous businesses in this field are actively seeking partnerships to bolster their market position. For example, in June 2022, Avesthagen Limited, an Indian company specializing in integrated systems biology platforms, embarked on a four-year strategic partnership with Wipro Limited, an India-based IT company. This alliance has allowed them to undertake a project named Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA, presenting a focus on genomics sequencing services linked to lung cancer. Similarly, in May 2022, Thermo Fisher Scientific, a US-based analytical instruments provider, joined forces with Qatar Genome Program (QGP), a part of Qatar Foundation (QF), to create an Axiom custom genotyping array for pan-Arab populations. This array, includes 800,000 variants, and aims to improve genomic research, particularly concerning health conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration aligns with Qatar’s national vision to boost population health and foster the growth of precision medicine for individuals of Arab descent globally. Thermo Fisher’s Axiom microarray technology plays a crucial role in speeding up precision medicine initiatives.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report
What Are the Key Elements That Define the DNA And Gene Chip Market?
A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person’s DNA has mutations in genes which are variations in DNA which can cause ailments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8205
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
